Efficacy of telaprevir-based therapy for difficult-to-treat patients with genotype 2 chronic hepatitis C in Japan.
about
Substitutions at NS3 Residue 155, 156, or 168 of Hepatitis C Virus Genotypes 2 to 6 Induce Complex Patterns of Protease Inhibitor ResistanceHepatitis C Virus Genotype 1 to 6 Protease Inhibitor Escape Variants: In Vitro Selection, Fitness, and Resistance Patterns in the Context of the Infectious Viral Life Cycle.Optimal therapy of genotype-2 chronic hepatitis C: what's new?Cost-utility analysis of sofosbuvir for the treatment of genotype 2 chronic hepatitis C in Japan.Efficacy and safety of telaprevir with natural human interferon-β and ribavirin in Japanese chronic hepatitis C patients with depression.Hepatocellular carcinoma or interferon-based therapy history attenuates sofosbuvir/ribavirin for Japanese genotype 2 hepatitis C virus.
P2860
Efficacy of telaprevir-based therapy for difficult-to-treat patients with genotype 2 chronic hepatitis C in Japan.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Efficacy of telaprevir-based t ...... chronic hepatitis C in Japan.
@en
type
label
Efficacy of telaprevir-based t ...... chronic hepatitis C in Japan.
@en
prefLabel
Efficacy of telaprevir-based t ...... chronic hepatitis C in Japan.
@en
P2093
P2860
P356
P1433
P1476
Efficacy of telaprevir-based t ...... chronic hepatitis C in Japan.
@en
P2093
Fumitaka Suzuki
Hiromitsu Kumada
Ichimaro Yamada
Joji Toyota
Kazuaki Chayama
Makoto Nakamuta
Masatoshi Ishigami
Miyoko Ochi
Takeshi Okanoue
P2860
P304
P356
10.1111/HEPR.12416
P577
2014-11-18T00:00:00Z